Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness

Gene Therapy

Volumn 15, Issue 9, 2008, Pages 660-667

  Huang, H Y ^a   Lee, C C ^a,b   Chiang, B L ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 5; LENTIVIRUS VECTOR; OVALBUMIN; SMALL INTERFERING RNA;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; DRUG EFFICACY; IMMUNE RESPONSE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM;

5' UNTRANSLATED REGIONS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE, TUMOR; CHEMOKINE CCL11; GENE THERAPY; INTERLEUKIN-5; LENTIVIRUS; LUNG; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVALBUMIN; PULMONARY EOSINOPHILIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

LENTIVIRUS; MURINAE; MUS;

EID: 42149136164     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.15     Document Type: Article

References (37)

1. Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 2004; 25: 477-482.
2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
3. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunoflourescence of eosinophil grantle major basir protein in lung tissues of patients with bronchial asthma. Lancet 1982; 2: 11-16.
4. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79: 3101-3109.
5. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N et al. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988; 157: 43-56.
6. Sanderson Q. Interleukin-5: An eosinophil growth and activation factor. Dev Biol Stand 1988; 69: 23-29.
7. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182: 1169-1174.
8. Wiktor-Jedrzejczak W. Eosinophil development. Immunol Today 1993; 14: 238.
9. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000; 106: 507-513.
10. Dubucquoi S, Desreumaux P. Janin A, Mein O, Goldman M, Tavernier J et al. Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion. J Exp Med 1994; 179: 703-708.
11. Walker C, Virchow Jr JC, Bruijnzeel PL, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146: 1829-1835.
12. Till S, Li B, Durham S, Humbert M, Assoufi B, Huston D et al. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/ macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 1995; 25: 2727-2731.
13. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156: 704-708.
14. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313-324.
15. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4: 15-24.
16. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyper-reactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
17. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.
18. Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: A pilot study. Am J Respir Crit Care Med 2003; 167: 1655-1659.
19. Buttner C, Lun A, Splettstoesser T, Kunkel G, Renz H. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003; 21: 799-803.
20. Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J et al Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 2005; 60: 693-696.
21. Popescu FD. Antisense- and RNA interference-based therapeutic strategies in allergy. J Cell Mol Med 2005; 9: 840-853.
22. Lee HJ, Koyano-Nakagawa N, Naito Y, Nishida J, Arai N, Arai K et al cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J Immunol 1993; 151: 6135-6142.
23. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989; 19: 701-705.
24. Dorman SC, Sehmi R, Gauvreau GM, Watson RM, Foley R, Jones GL et al Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 2004; 169 565-572.
25. Park CS, Choi YS, Ki SY, Moon SH, Jeong SW, Uh ST et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur Respir J 1998; 12: 872-878.
26. Kung TT, Stelts DM, Zurcher JA, Adams III GK, Egan RW, Kreutner W et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 1995; 13: 360-365.
27. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183: 109-117.
28. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004; 113: 115-119.
29. Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006; 118: 1133-1141.
30. Karras JG, McGraw K, McKay RA, Cooper SR, Lerner D, Lu T et al. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol 2000; 164: 5409-5415.
31. Pebernard S, Iggo RD. Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 2004; 72: 103-111.
32. Lee CC, Huang HY, Chiang BL. Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 2008; 16: 60-65.
33. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21: 635-637.
34. Saxena S, Jonsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 2003; 278: 44312-44319.
35. Lee YL, Ye YL, Yu CI, Wu YL, Lai YL, Ku PH et al. Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum Gene Ther 2001; 12: 2065-2079.
36. Chuang YH, Fu CL, Lo YC, Chiang BL. Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Therapy 2004; 11: 1497-1505.
37. Glaab T, Mitzner W, Braun A, Ernst H, Korolewitz R, Hohlfeld JM et al Repetitive measurements of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing mice. J Appl Physiol 2004; 97: 1104-1111.